KO, JIUNN LIANG,柯俊良,HOU, TING YI,侯婷译,侯婷譯,WU, MING FANG,吴铭芳,吳銘芳,CHEN, TZU CHIH,陈子智,陳子智
申请号：
TW104107531
公开号：
TW201622740A
申请日:
2015.03.10
申请国别(地区):
TW
年份:
2016
代理人:
摘要：
The invention generally relates to an immunomodulatory protein and a chemotherapeutic agent for simultaneous, contemporaneous or sequential use in the treatment of diseases, more particularly of proliferative diseases, still more particularly of cancer(s), to a combination of an FIP and a chemotherapeutic agent, as well as to the medical and biotechnological applications thereof, more particularly in the field of the treatment of diseases, more particularly of proliferative diseases, still more particularly of cancer(s).本發明大致上關於同時地、同期地或依序地用於治療疾病、尤其是用於治療增生性疾病、更尤其是用於治療一或多種癌症的免疫調節蛋白與化學治療用藥劑。本發明亦關於由真菌免疫調節蛋白(FIP)與化學治療用藥劑所構成的組合，以及關於彼等的醫藥與生技用途，特別是在治療疾病、尤其是在治療增生性疾病，更尤其是在治療一或多種癌症之領域上的醫藥與生技用途。
